Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
EPSTATE SR 150Epalr
EPSTATE SR 150Epalr
COD not available
DIABETIC RANGE by EPSTATE SR 150

EPSTATE SR 150

INR 132.3 INR 189
You Save: INR 56.7 (30%)

Description

Product details

EPSTATE SR 150 Epalrestat Tablets ER (50mg) EPSTATE SR 150 is a medication containing Epalrestat Tablets ER (50mg) as its active ingredient. Epalrestat is an aldose reductase inhibitor used primarily in the management of diabetic neuropathy. The sustained-release formulation ensures a steady release of the medication over an extended period, allowing for convenient once-daily dosing. Diabetic neuropathy is a common complication of diabetes characterized by nerve damage, often causing pain, tingling, and numbness in the extremities. Epalrestat works by inhibiting aldose reductase, an enzyme involved in the polyol pathway. By blocking this enzyme, Epalrestat helps prevent the accumulation of sorbitol, a sugar alcohol that can build up in nerve cells and contribute to nerve damage. EPSTATE SR 150 is indicated for the treatment of diabetic neuropathy to alleviate symptoms and potentially slow the progression of nerve damage. By addressing the underlying mechanism of neuropathy, it offers patients relief from pain and discomfort associated with this condition, improving their quality of life. As with any medication, EPSTATE SR 150 may cause side effects such as gastrointestinal disturbances, skin reactions, or liver function abnormalities. Patients should be monitored regularly for these adverse effects, and dosage adjustments may be necessary based on individual response and tolerability. Overall, EPSTATE SR 150 provides an effective treatment option for diabetic neuropathy, offering the convenience of once-daily dosing with its sustained-release formulation. However, it should only be used under the supervision of a healthcare professional and as part of a comprehensive management plan for diabetic neuropathy, which may include lifestyle modifications, blood sugar control, and other therapies aimed at symptom management and preventing further nerve damage. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order Now https://www.sterisonline.com/product/epstate-sr-150-133910

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us